This is where konjac fibre earns its place, and it is not the reason most people buy it. The evidence covers 2 metabolic outcomes across 18 trials.
Twelve studies in 370 people found lower LDL cholesterol. Six trials in 440 people with type 2 diabetes found fasting glucose down 1.08.
Quick Answer: Does Glucomannan Lower Cholesterol and Blood Sugar?
Yes, on reasonably consistent evidence. Konjac glucomannan significantly lowered LDL cholesterol across 12 randomized trials in 370 people. In type 2 diabetes, 6 trials in 440 people found fasting glucose down 1.08, 2-hour glucose down 1.92, fasting insulin down 1.59 and LDL down 0.35. This is the ingredient's real use, rather than weight loss.
Key Takeaways
- Twelve randomized trials in 370 people found significantly lower LDL.
- Eight of those 12 were in adults and 4 were in children.
- In type 2 diabetes, 6 trials found fasting glucose down 1.08.
- The same 6 trials found 2-hour glucose down 1.92 after meals.
- A larger lipid analysis moved 3 measures and left 4 unchanged.
Related Products
The LDL Evidence
This is the most focused body of evidence konjac fibre has, and it was assembled specifically for lipid targets.
- Studies: 12, in 370 people in total.
- Split: 8 in adults and 4 in children.
- Minimum duration: 3 weeks of follow-up.
- Finding: LDL cholesterol significantly lowered.
The reviewers called trials in this area scarce and limited in sample size and duration, which is a fair caveat to carry alongside the result.[1]A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B — The American Journal of Clinical Nutrition (2017) View source The broader picture is in what this fibre actually is.
The Wider Lipid Analysis, With Its Caveats
A larger 2024 analysis went further and its own numbers argue for caution.
| Measure | Result | Moved? |
|---|---|---|
| Total cholesterol | SMD 3.299 lower, I-squared 95.41% | Yes |
| LDL cholesterol | SMD 2.993 lower, I-squared 95.49% | Yes |
| Apolipoprotein B1 | SMD 2.2 lower | Yes |
| Triglycerides | No significant change | No |
| Apolipoprotein A1 | No significant change | No |
| LDL to HDL ratio | No significant change | No |
Heterogeneity above 95% means the included studies disagreed with each other enormously, so the direction is more trustworthy than the size.[2]The effect of glucomannan supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis — BMC Cardiovascular Disorders (2024) View source Three measures moved and 4 did not, which is the honest summary.
Blood Glucose in Type 2 Diabetes
The most coherent positive signal in this whole topic is in people who already have a metabolic diagnosis.
| Outcome | Change against control |
|---|---|
| Fasting blood glucose | Down 1.08 |
| 2-hour post-meal glucose | Down 1.92 |
| Fasting insulin | Down 1.59 |
| Total cholesterol | Down 0.38 |
| LDL cholesterol | Down 0.35 |
Those came from 6 randomized trials in 440 participants.[3]Effects of Glucomannan Supplementation on Type II Diabetes Mellitus in Humans: A Meta-Analysis — Nutrients (2023) View source Anyone taking glucose-lowering medication should treat this as an addition to that medication and raise it at their next review, not as a replacement. Amounts are in how people actually take it.
Why This Is the Real Case for Konjac
Setting the marketing aside leaves a narrow and defensible position.
- LDL: 12 trials, and this is the best-supported use.
- Glucose: 6 trials, in people with type 2 diabetes.
- Weight: No difference from placebo across 8 weeks.
- Mechanism: Viscosity, which is why the water rule exists.
The weight evidence is set out in full in the weight claim, examined, and it is the opposite of this page.
| Goal | Is konjac fibre a reasonable choice? |
|---|---|
| Lowering LDL cholesterol | Yes, on 12 randomized trials |
| Blood glucose with type 2 diabetes | Yes, alongside a clinician |
| Losing weight | No, on the 1 trial that tested it |
| Replacing a statin | No, and never |
If lipids or glucose are the goal, a 1000 mg konjac capsule is a reasonable thing to add to a diet, taken with a full glass of water and spaced from medication.
Speak to a Clinician Rather Than Self-Managing If
- Chest pain, difficulty swallowing or a sensation of something stuck after a capsule, which can indicate oesophageal obstruction and is an emergency
- Severe abdominal pain, vomiting, or bloating with no bowel movement
- Any history of swallowing difficulty, oesophageal narrowing or previous bowel obstruction
- Taking it without a full glass of water, or lying down soon afterwards
- Giving konjac jelly or mini-cup confectionery to a young child
Frequently Asked Questions
Does glucomannan lower cholesterol? +
Yes. Across 12 randomized trials in 370 people, konjac glucomannan significantly lowered LDL cholesterol.
What are the benefits of taking glucomannan? +
Lower LDL cholesterol across 12 trials in 370 people, and in type 2 diabetes lower fasting glucose, 2-hour glucose and fasting insulin across 6 trials.
Does glucomannan help blood sugar? +
In type 2 diabetes, 6 trials in 440 people found fasting glucose down 1.08 and 2-hour post-meal glucose down 1.92.
Can I take it with diabetes medication? +
Raise it at your next review, since glucose-lowering effects add together. Space the capsule at least 2 hours from any medicine.
How long before cholesterol changes? +
The pooled trials required at least 3 weeks of follow-up. Any fair test should run longer than 1 month.
Is glucomannan good for gut health? +
It is a viscous soluble fibre, and its measured effects here are metabolic. Three lipid measures moved in the larger analysis and 4 did not.
Does it lower triglycerides? +
No. Triglycerides showed no significant change in the 2024 analysis, along with 3 other lipid measures.
Is glucomannan safe to take daily? +
It was well tolerated across 8 weeks in a 53-person trial, with 0 safety outcomes differing from placebo. It is not a replacement for prescribed lipid treatment.
Who should not take glucomannan? +
Anyone with swallowing difficulty or a previous bowel obstruction. Four of the 12 LDL trials were in children, and that remains a clinician question.
Is fibre from food as good? +
Food fibre brings everything else in the food with it. A supplement offers 1 advantage, which is a measured amount taken consistently.
Related Reading
Related Products
